[Trachomatous entropion trichiasis and its surgical treatment].

R. Nataf,G. Coscas

1963-05-01

Abstract:

What problem does this paper attempt to address?

Β,β-Dimethylacrylshikonin Induces Mitochondria Dependent Apoptosis Through ERK Pathway in Human Gastric Cancer SGC-7901 Cells.

Xiu-Jin Shen,Hai-Bing Wang,Xiao-Qiong Ma,Jiang-Hua Chen

DOI: https://doi.org/10.1371/journal.pone.0041773

IF: 3.7

2012-01-01

PLoS ONE

Abstract:β,β-Dimethylacrylshikonin, one of the active components in the root extracts of Lithospermum erythrorhizon, posses antitumor activity. In this study, we discussed the molecular mechanisms of β,β-dimethylacrylshikonin in the apoptosis of SGC-7901 cells. β,β-Dimethylacrylshikonin reduced the cell viability of SGC-7901 cells in a dose- and time-dependent manner and induced cell apoptosis. β,β-Dimethylacrylshikonin treatment in SGC-7901 cells down-regulated the expression of XIAP, cIAP-2, and Bcl-2 and up-regulated the expression of Bak and Bax and caused the loss of mitochondrial membrane potential and release of cytochrome c. Additionally, β,β-dimethylacrylshikonin treatment led to activation of caspases-9, 8 and 3, and cleavage of poly (ADP-ribose) polymerase (PARP), which was abolished by pretreatment with the pan-caspase inhibitor Z-VAD-FMK. β,β-Dimethylacrylshikonin induced phosphorylation of extracellular signal-regulated kinase (ERK) in SGC-7901 cells. U0126, a specific MEK inhibitor, blocked the ERK activation by β,β-dimethylacrylshikonin and abrogated β,β-dimethylacrylshikonin -induced apoptosis. Our results demonstrated that β,β-dimethylacrylshikonin inhibited growth of gastric cancer SGC-7901 cells by inducing ERK signaling pathway, and provided a clue for preclinical and clinical evaluation of β,β-dimethylacrylshikonin for gastric cancer therapy.
The In Vitro and In Vivo Anticancer Properties of Chalcone Flavokawain B through Induction of ROS-Mediated Apoptotic and Autophagic Cell Death in Human Melanoma Cells

You-Cheng Hseu,Yu-Chi Chiang,Yugandhar Vudhya Gowrisankar,Kai-Yuan Lin,Sheng-Teng Huang,Sirjana Shrestha,Geng-Ruei Chang,Hsin-Ling Yang

DOI: https://doi.org/10.3390/cancers12102936

2020-10-12

Cancers

Abstract:Melanoma is the most prevalent type of skin cancer with high mortality rates. This study demonstrates the in vitro and in vivo anticancer properties of chalcone flavokawain B (FKB) induced ROS-mediated apoptosis and autophagy in human melanoma (human epithelial melanoma cell line A375 and/or human skin lymph node derived melanoma cell line A2058) cells. Cell viability was calculated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and the expression patterns of various apoptosis, autophagy-associated proteins were determined by Western blot methods. Annexin V was detected by flow cytometry, whereas acidic vesicular organelles (AVOs) and intracellular ROS levels were measured by fluorescence microscopy. The in vivo anticancer properties of FKB were evaluated by xenografting the A375 cells into nude mice. The results convey that FKB inhibited cell viability, B-Raf proto-oncogene, serine/threonine kinase (BRAF)/extracellular signal-regulated kinase (ERK) expression in human melanoma cells. Caspase-3 activation, poly (ADP-ribose) polymerase (PARP) cleavage pathway, and Bcl2 associated X (Bax)/B-cell lymphoma 2 (Bcl-2) dysregulation were involved in the execution of apoptosis. Moreover, FKB-induced autophagy was observed through increased microtubule-associated protein 1A/1B-light chain 3B (LC3-II) accumulation and AVOs formation, which was also associated with an increase in sequestosome 1 (SQSTM1/p62), decreased protein kinase B (AKT)/mammalian target of rapamycin (mTOR) expressions, and dysregulated Beclin-1/Bcl-2 levels. Autophagy inhibitors [3-methyladenine (3-MA)/chloroquine (CQ)] and LC3 silencing suppressed FKB-induced apoptosis by decreasing caspase-3 in melanoma cells. The antioxidant N-acetylcysteine (NAC) diminished FKB-induced apoptotic and autophagic cell death. However, the inhibition of apoptosis decreased FKB-induced autophagy (LC3-I/II). The in vivo study confirmed that FKB inhibited melanoma growth in A375-xenografted nude mice. This study concluded that FKB is critically associated with the execution and generation of ROS-modulated apoptotic and autophagic cell death of melanoma cells. FKB also repressed tumor growth in xenografted nude mice. Therefore, flavokawain B might be a potential anti-tumor agent in human melanoma treatment.

oncology
Biochanin A induces anticancer effects in SK-Mel-28 human malignant melanoma cells via induction of apoptosis, inhibition of cell invasion and modulation of NF-κB and MAPK signaling pathways

Peng Xiao,Jia Yang,Bowen Zheng,Jiaming Sun

DOI: https://doi.org/10.3892/ol.2017.6945

2017-09-14

Oncology Letters

Abstract:The present study aimed to investigate the antitumor activity of Biochanin A in SK-Mel-28 human malignant melanoma cells. An MTT assay was used to study the cytotoxic effects of Biochanin A. In vitro wound healing and invasion assays were used to investigate the effects on cell migration and invasion. Fluorescence microscopy using acridine orange/propidium iodide was used to study effects on cell morphology and apoptosis. Nuclear factor (NF)-κB and mitogen-activated protein kinase (MAPK) protein expression levels were determined by western blot analysis. The results indicated that Biochanin A significantly inhibited the growth of SK-Mel-28 cells in a dose and time dependent manner. Treatment of the cells with Biochanin A induced apoptosis in a dose dependent manner. Additionally, Biochanin A led to inhibition of cell migration and invasion in a dose-dependent manner and upregulated the expression of key proteins in the NF-κB and MAPK signaling pathways.

Medicine,Biology,Chemistry
Ailanthone Induces Cell Cycle Arrest and Apoptosis in Melanoma B16 and A375 Cells

Wenjing Liu,Xiaona Liu,Zhaohai Pan,Dan Wang,Minjing Li,Xiaoyu Chen,Ling Zhou,Maolei Xu,Defang Li,Qiusheng Zheng

DOI: https://doi.org/10.3390/biom9070275

IF: 6.064

2019-07-11

Biomolecules

Abstract:Malignant melanoma is the most lethal type of skin cancer. Previous studies have shown that ailanthone has potent antitumor activity in a variety of cell lines. However, the anti-tumor effect of ailanthone on malignant melanoma remains unclear. To investigate the anti-tumor mechanisms of ailanthone in human melanoma B16 and mouse melanoma A375 cells, the cell counting kit-8 assay, colony formation assay, DNA content analysis, Hoechst 33258, and Annexin V-FITC/PI staining were used to assess cell proliferation, cell cycle distribution, and cell apoptosis, respectively. Western blotting was performed to evaluate the expression of cell cycle- and apoptosis-related proteins and regulatory molecules. The results showed that ailanthone significantly inhibited melanoma B16 and A375 cell proliferation as well as remarkably induced cell cycle arrest at the G0–G1 phase in B16 cells and the G2–M phase in A375 cells in a dose-dependent manner. Further investigation revealed that ailanthone promoted the expression of p21 and suppressed the expression of cyclin E in B16 cells or cyclin B in A375 cells through the PI3K-Akt signaling pathway. In addition, ailanthone induced B16 and A375 cell apoptosis via a caspase-dependent mechanism. Further studies showed that ailanthone remarkably downregulated Bcl-2 and upregulated Apaf-1 and Bax, and subsequently increased mitochondrial membrane permeabilization and released cytochrome c from the mitochondria in B16 cells and A375 cells. Taken together, ailanthone induces cell cycle arrest via the PI3K-Akt signaling pathway as well as cell apoptosis via the mitochondria-mediated apoptotic signaling pathway. Ailanthone may be potentially utilized as an anti-tumor agent in the management of malignant melanoma.

biochemistry & molecular biology
Effects of Matrine on the Proliferation and Apoptosis Induction in Human Malignant Melanoma Cell Line A375

LIU Xiao-yan,FANG Hong,YANG Zheng-gang,TENG Li-song,WANG Yi-na,DING Ying-guo,JIANG Xiao-ling

DOI: https://doi.org/10.3321/j.issn:1001-2494.2007.18.005

2007-01-01

Abstract:OBJECTIVE To investigate the effects of matrine on cellular proliferation and apoptosis in human malignant melanoma cell line A375 in vitro. METHODS The A375 cells were cultured with different concentrations of matrine.The inhibition of cellular proliferation was determined by measuring MTT dye absorption of the living cells. The apoptosis was assessed by the Annexin-V-FIFT/PI affinity assay. The morphological changes of A375 cells were observed by light and electron microscopy. RESULTS Matrine significantly inhibited the proliferation of A375 cells in a dose-and time-dependented manner. The outcome of flow cytometry showed that matrine induced more Annexin-V stained cells in a dose-dependented manner,which was proved by light and electron microscopy. CONCLUSION Matrine plays an inhibitory role in the tumor cell proliferation and induces the cell apoptosis in malignant melanoma cells.
Experimental Dipetalonema reconditum infections in dogs.

B. Lindemann,J. Mccall

DOI: https://doi.org/10.2307/3281950

1984-02-01

Journal of Parasitology

Abstract:Dipetalonema reconditum is a filarid nematode residing subcutaneously in dogs, and is transmitted by fleas. Previous studies on experimental infections are limited to those by Pennington (1972, Diss. Abst. 33B: 772-B) and Farnell and Faulkner (1978, J. Parasit. 64: 565567). Thus the purposes of our study were: 1) to determine whether dogs could be infected experimentally with D. reconditum by subcutaneous and transmucosal inoculation; 2) to determine whether cats and jirds were susceptible to D. reconditum following subcutaneous inoculation; and 3) to compare microfilaremias during the course of infection in dogs inoculated subcutaneously or transmucosally. A stray dog with a naturally acquired infection was the original source of D. reconditum. Microfilariae were identified by morphological features (Redington, B. C., et al., 1978. In Proceedings of the heartworm symposium '77, G. F. Otto (ed.). Veterinary Medicine Publishing Co., Bonner Springs, Kansas, pp. 14-21) and acid phosphatase activity (Chalifoux and Hunt, 1971, J. Am. Vet. Med. Assoc. 158: 601-605). Ctenocephalides felis pupae were purchased from Environmental Consultants, Inc., Norfolk, Virginia, and reared to adulthood (Smith and Eddy, 1954, Bull. Wld. Hlth. Org. 10: 127-137). Adult fleas were placed on the infected dog and rem ved 10 to 14 days later. Procedures for harvesting infective nematode larvae were similar to those described for Brugia pahangi by McCall (1981, J. Georgia Entomol. Soc. 16: 283-293). In the first experiment, 11 microfilaria-free dogs were inoculated (Table I). Transmucosal and transcutaneous inoculations were performed by placing infective nematode larvae on the vestibular mucosa and shaved skin, respectively, of anesthetized dogs. In addition, two cats and six Mongolian jirds were inoculated subcutaneously with 22 to 25 larvae per animal. In the second experiment, six microfilaria-free Beagles were inoculated subcutaneously and four were inoculated transmucosally with 30 larvae per animal. Modified Knott tests were performed weekly for 28 wk PI. The degree of microfilaremia was com-
Inhibitory effect of matrine on the in vitro invasiveness of human malignant melanoma cell line A375

LIU Xiao-yan,FANG Hong,TENG Li-song,YANG Zheng-gang,ZHANG Xing-guo,刘晓艳,方红,滕理送,羊正纲,张幸国,蒋筱凌

DOI: https://doi.org/10.3760/j.issn:0412-4030.2006.06.010

2006-01-01

Chinese Journal of Dermatology

Abstract:Objective To investigate the inhibitory effect of matrine on the invasiveness of human malignant melanoma cell line A375,and the mechanism of this effect.Methods MTT assay and Annex- in-V-FIFT/PI double staining were performed to examine the effects of matrine on the proliferation and apoptosis of A375 cells.Semi-quantitative RT-PCR was used to evaluate the mRNA expression of hep- aranase in the treated cells.The adhesion and invasiveness of A375 cells were tested by cell-matrigel adhe- sion assay and matrigel invasion assay,respectively.Results Matrine (≥0.5 mg/mL) significantly inhibit- ed the proliferation of A375 cells,and induced apoptosis of these cells;both effects were in a dose-depen- dent manner.The heparanase-mRNA expression in A375 cells were significantly decreased by 0.125～0.5 mg/mL matrine,as were the adhesion and invasiveness of these cells (all P＜0.01);all the effects were in a dose-dependent manner (P＜0.01).Conclusions Matrine inhibited the adhesion and invasiveness of A375 cells in vitro.These effects could be due to the inhibition of cellular proliferation,induction of cellu- lar apoptosis and down-regulation of heparanase-mRNA expression.
The Inhibitory Effect of 3Β-Hydroxy-12-oleanen-27-oic Acid on Growth and Motility of Human Hepatoma HepG2 Cells Through JNK and Akt Signaling Pathway

Juanjuan Wang,Xiangfeng Chen,Zhihua Zhou,Jinhui Li,Hongxiang Sun

DOI: https://doi.org/10.1155/2013/685159

IF: 2.65

2013-01-01

Evidence-based Complementary and Alternative Medicine

Abstract:3β-Hydroxy-12-oleanen-27-oic acid (ATA) was a main antitumor active triterpene from the rhizomes ofAstilbe chinensis. In this study, we investigated its effects on growth, apoptosis, cell cycle, motility/invasion, and metatasis in human hepatoma HepG2 cellsin vitroand antimetastasis of B16-F10 melanoma in micein vivo, as well as its molecular mechanisms of action using a high-throughput Cancer Pathway Finder PCR Array. ATA could not only induce tumor cells into apoptosis through the activation of both extrinsic and intrinsic pathways, arrest HepG2 cells in G2/M phase, but also suppress the invasion and metastasis abilities of HepG2 cells and the lung metastasis of B16-F10 melanoma in mice. PCR array assay revealed that ATA upregulated 9 genes including CDKN1A, MDM2, CFLAR (CASPER), TNFRSF10B (DR5), c-Jun, IL-8, THBS1, SERPINB5 (maspin), and TNF and downregulated 8 genes such as CCNE1, AKT, ANGPT1, TEK, TGFBR1, MMP9, U-PA, and S100A4. These results indicate that ATA could exert antitumor effects through activating JNK/MAPK and suppressing AKT signal transduction pathways and that ATA might be a potent anticancer agent.
Effect of resveratrol on the proliferation and apoptosis of melanoma cell line A375 cells

Yan Yuehua,Xu Li,Wu Jianbo,Sheng Wanxiang

DOI: https://doi.org/10.3969/j.issn.1008-8849.2013.26.001

2013-01-01

Abstract:Objective It is to investigate the effects of resveratrol on the proliferation and apoptosis of melanoma cell line A375 cells in vitro and its possible function and mechanism.Methods After the A375 cells were treated with resveratrol of different concentrations,the inhibitory effect was detected by MTT and taipanlan staining,the apoptosis was detected by PI staining and terminal deoxynucleotidy transferase-mediated dUTP nick end-labeling(TUNEL) assay.Results Resveratrol of different concentrations can inhibit the proliferation and enhance the apoptosis of the A375 cells,and the effects were time and dose dependent.Conclusion Resveratrol of certain concentration can inhibit the proliferation of A375 cells,which mostly through inducing apoptosis,especially early apoptosis.
Axitinib, a selective inhibitor of vascular endothelial growth factor receptor, exerts an anticancer effect in melanoma through promoting antitumor immunity.

Xiaohua Zhang,Xianying Fang,Zhenzhen Gao,Wei Chen,Feifei Tao,Peifen Cai,Huaqin Yuan,Yongqian Shu,Qiang Xu,Yang Sun,Yanhong Gu

DOI: https://doi.org/10.1097/CAD.0000000000000033

2014-01-01

Anti-Cancer Drugs

Abstract:In this study, we investigated the antitumor activity of axitinib, a selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases, against melanoma cells. Axitinib dose-dependently inhibited the proliferation and induced the apoptosis of B16F1 cells in vitro. In a mouse model of melanoma xenograft, axitinib significantly suppressed tumor growth and induced apoptosis of cells in tumor tissues at a dose of 25 mg/kg. In addition, axitinib suppressed the lung metastasis of melanoma cells and prolonged the life span of tumor-bearing mice. Axitinib also enhanced the proportion of CD8(+) T cells and reduced the proportion of myeloid-derived suppressor cells in CD45.2(+) cells, whereas the proportions of CD4(+) T cells and Treg cells were not affected. The mRNA expressions of inducible nitric oxide synthases-2 and arginase-1, which were associated with the function of myeloid-derived suppressor cells in tumor tissues, were inhibited by axitinib. Moreover, axitinib suppressed the expressions of proinflammatory cytokines such as IL-6, TNF-, and IFN-. Altogether, our results showed the unique antitumor mechanism of axitinib and provided useful information for its clinical application. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient

F. Pea,P. Cojutti,R. Sbrojavacca,B. Cadeo,F. Cristini,A. Bulfoni,M. Furlanut

DOI: https://doi.org/10.1345/aph.1P745

2011-07-01

Abstract:Objective: To describe a case of severe cellulitis, successfully treated with high-dose daptomycin plus continuous infusion meropenem, in a patient with morbid obesity and renal failure, in whom drug exposure over time was optimized by means of realtime therapeutic drug monitoring (TDM). Case Summary: A 63-year-old man with morbid obesity (body mass index 81.6 kg/m2) and renal failure was admitted to the emergency department because of severe cellulitis. The patient had an admission Laboratory Risk Indicator for Necrotizing Fasciitis score of 9, and broad-spectrum antimicrobial therapy with daptomycin and meropenem was started. Because of rapidly changing renal function, dosage adjustments were guided by an intensive program of TDM (daptomycin ranging from 1200 mg every 48 hours over 30 minutes to 1200 mg every 36 hours over 30 minutes; meropenem ranging from 0.25 g every 8 hours over 6 hours to 500 mg every 4 hours by continuous infusion). Clinical response was observed within 72 hours. However, a sudden increase of serum creatine kinase (SCK) raised questions about the need for discontinuation of daptomycin. The drug concentrations were not toxic; therefore, we decided to continue therapy. Significant clinical improvement, with SCK normalization, was observed within a few days. Antimicrobial therapy was switched on day 29 to amoxicillin/clavulanate plus levofloxacin, and then discontinued at discharge on day 53. Discussion: High-dose daptomycin plus continuous infusion meropenem may ensure adequate empiric antimicrobial coverage in patients with possible early necrotizing fasciitis. However, in patients with morbid obesity and changing renal function, significant challenges may arise because of the hydrophilic nature of these drugs and the inaccuracy of standard methods of estimating renal function. Conclusions: Real-time TDM may represent an invaluable approach in optimizing drug exposure with high-dose daptomycin plus continuous infusion meropenem in patients with severe cellulitis, morbid obesity, and changing renal function.
Shikonin Derivative Dmako-05 Inhibits Akt Signal Activation and Melanoma Proliferation

Yao-yao Yang,Hui-qiong He,Jia-hua Cui,Yun-juan Nie,Ya-xian Wu,Rui Wang,Gang Wang,Jun-Nian Zheng,Richard D. Ye,Qiong Wu,Shao-shun Li,Feng Qian

DOI: https://doi.org/10.1111/cbdd.12722

2016-01-01

Chemical Biology & Drug Design

Abstract:DMAKO-05((S)-1-((5E, 8E)-5,8-bis(hydroxyimino)-1,4-dimethoxy-5,8-dihydronaphthalen-2-yl)-4-methylpent-3enyl 3-methylbutanoate) is a novel oxime derivative of shikonin, the major component extracted from Chinese herb Lithospermun erythrorhizon. Here, we report that DMAKO-05 had an antitumor activity against mouse melanoma cell line B16F0. Our studies indicated that DMAKO-05 not only inhibited B16F0 proliferation and migration but also led to cell cycle arrest at G1 phase and cell apoptosis, in which DMAKO-05 triggered mitochondrial-mediated apoptosis signal including caspase- 9/3 and PARP. In response to DMAKO-05 treatment, the Akt-mediated survival signals were remarkably attenuated in B16F0 cells. Collectively, DMAKO-05 has a strong cytotoxicity in B16F0 cells via inhibiting Akt activation, inducing G1 arrest, and promoting B16F0 cell apoptosis. DMAKO-05 might serve as a potential candidate lead compound for melanoma.
5-aminolevulinic-acid-mediated sonodynamic therapy improves the prognosis of melanoma by inhibiting survivin expression

Haixia Fan,Zheng Hu,Shan Wang,Wen Wu,Xue Liu,Haixia Geng

DOI: https://doi.org/10.3233/CBM-190681

2020-01-01

Cancer Biomarkers

Abstract:BACKGROUND: This study aimed to evaluate the relationship between survivin expression and melanoma after 5-aminolevulinic acid (5-ALA)-mediated sonodynamic therapy. METHODS: Immunohistochemistry was used to detect survivin protein expression in human melanoma clinical samples. Subsequently, the effects of 5-ALA-mediated sonodynamic therapy were determined by measuring the volume of melanoma xenografts and the bodyweights of melanoma-bearing nude mice. The MTT assay was used to detect the viability of melanoma B16-F10 cells under the action of 5-ALA-mediated sonodynamic therapy, and Western blotting and PCR were used to detect survivin expression in melanoma cells and in the melanoma-xenograft model. RESULTS: Survivin expression was significantly upregulated in human melanoma tissues compared with that of non-melanoma tissues. In the in vivo case, 5-ALA-mediated sonodynamic therapy significantly delayed tumor growth, prolonged the survival of mice, and inhibited the expression of survivin. In the in vitro case, 5-ALA-mediated sonodynamic therapy inhibited B16-F10 cell proliferation and decreased survivin expression at both protein and mRNA levels. CONCLUSION: Our results suggest that 5-ALA-mediated sonodynamic therapy inhibited B16-F10 cell proliferation and melanoma-xenograft growth and prolonged survival of melanoma-bearing nude mice, which might be through downregulation of survivin expression.
Nitidine Chloride Inhibits Proliferation and Induces Mitochondrial-Mediated Apoptosis of Human Melanoma A375 and A2058 Cells In Vitro

Yexian Li,Yue Yao,Linxi Zeng,Jinfang Zhang,Guoqiang Zhang

DOI: https://doi.org/10.1134/s1062359023700449

2024-01-10

Biology Bulletin

Abstract:Melanoma is a malignant tumor transforming from normal melanocytes, with strong invasion and low survival rate. Nitidine chloride (NC) is a natural benzophenidine alkaloid extracted from the roots of traditional Chinese medicine zanthoxylum nitidum. In recent years, many studies have found that NC may have strong anti-tumor activity. However, the efficacy of NC against melanoma has rarely been reported, and the potential molecular mechanism remains unknown. Our study explored the effects of NC on the proliferation and apoptosis of human melanoma A375 and A2058 cells. CCK-8 was utilized to detect the effects of different concentrations of NC on the proliferation of A375 and A2058 cells. Within a certain concentration and time range, NC can inhibit the viability of A375 and A2058 cells significantly in a time-dose-dependent manner. In addition, NC-induced apoptosis was confirmed by DAPI staining and flow cytometry analysis of Annexin V-FITC/PI. Moreover, we observed that the ratio of Bax/Bcl-2 in the cytoplasm increases, activating Caspase-3/-9 and ultimately inducing apoptosis via the mitochondrial pathway. Our study indicated that NC has anti-tumor properties against human melanoma cells through inhibiting proliferation and inducing apoptosis. Therefore, the results provide new insights for future work on the utilization of NC in malignant melanoma treatment.

biology
A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products

Keke Li,Shuang Zhao,Jing Long,Juan Su,Lisha Wu,Juan Tao,Jianda Zhou,JiangLin Zhang,Xiang Chen,Cong Peng

DOI: https://doi.org/10.1186/s12935-020-1114-5

IF: 6.429

2020-01-30

Cancer Cell International

Abstract:Abstract Background Melanoma is one of the most aggressive tumors with the remarkable characteristic of resistance to traditional chemotherapy and radiotherapy. Although targeted therapy and immunotherapy benefit advanced melanoma patient treatment, BRAFi (BRAF inhibitor) resistance and the lower response rates or severe side effects of immunotherapy have been observed, therefore, it is necessary to develop novel inhibitors for melanoma treatment. Methods We detected the cell proliferation of lj-1-59 in different melanoma cells by CCK 8 and colony formation assay. To further explore the mechanisms of lj-1-59 in melanoma, we performed RNA sequencing to discover the pathway of differential gene enrichment. Western blot and Q-RT-PCR were confirmed to study the function of lj-1-59 in melanoma. Results We found that lj-1-59 inhibits melanoma cell proliferation in vitro and in vivo, induces cell cycle arrest at the G2/M phase and promotes apoptosis in melanoma cell lines. Furthermore, RNA-Seq was performed to study alterations in gene expression profiles after treatment with lj-1-59 in melanoma cells, revealing that this compound regulates various pathways, such as DNA replication, P53, apoptosis and the cell cycle. Additionally, we validated the effect of lj-1-59 on key gene expression alterations by Q-RT-PCR. Our findings showed that lj-1-59 significantly increases ROS (reactive oxygen species) products, leading to DNA toxicity in melanoma cell lines. Moreover, lj-1-59 increases ROS levels in BRAFi -resistant melanoma cells, leading to DNA damage, which caused G2/M phase arrest and apoptosis. Conclusions Taken together, we found that lj-1-59 treatment inhibits melanoma cell growth by inducing apoptosis and DNA damage through increased ROS levels, suggesting that this compound is a potential therapeutic drug for melanoma treatment.

oncology
Anti-cancer activity of Annexin V in murine melanoma model by suppressing tumor angiogenesis.

Xuerui Zhang,Lina Huo,Haibo Jin,Yuheng Han,Jie Wang,Yanjun Zhang,Xinghuan Lai,Ziwei Le,Jing Zhang,Zichun Hua

DOI: https://doi.org/10.18632/oncotarget.16645

2017-01-01

Oncotarget

Abstract:Annexin V, a protein with high affinity to phosphatidylserine (PS) in a calcium dependent manner, has been widely used to probe apoptosis. Annexin V in inhibiting engulfment of apoptotic cells by macrophages had been reported to increase the immunogenicity of tumor cells undergoing apoptosis. However, far less is known about its multiple properties, especially in cancer therapies. Here we found that Annexin V had a good anti-tumor activity in murine melanomaxenograft model. Treatment with Annexin V showed significant reduction in tumor size and remarkable tumor necrosis areas. The serum level of VEGF was downregualted by Annexin V both in normal mice and mice bearing tumor, suggesting that its new role on impeding tumor angiogenesis. In Silico analysis using Oncomine database, we also found the negative correlation of AnnexinV and VEGF both in skin and melanoma. The decreased Annexin V expression shows linearity relation with the elevated VEGF expression. These data provided a possibility that Annexin V can be used as a novel angiogenesis inhibitor in tumor therapy.
Selective Antitumor Effect of Shikonin Derived DMAKO-20 on Melanoma through CYP1B1

Junqi Cui,Xiaobo Zhou,Jia Huang,Jiahua Cui,Jun Chen

DOI: https://doi.org/10.2174/1568009620666201116112937

2020-11-15

Abstract:Background: CYP1B1 is recognized as a valuable target for chemotherapy. It catalyzes the bioactivation of naphthoquinone oximes within certain cancer cell lines. However, the expression level of CYP1B1 in melanoma and the functional role regulating the activity of DMAKO-20 as a representative naphthoquinone oxime against skin carcinoma is still unknown. Objective: We sought to examine the expression level of CYP1B1 in melanoma and explore the molecular mechanism behind the anticancer effects of DMAKO-20 in melanoma. Methods: CYP1B1 expression levels in paraffin specimens taken from melanoma patients, and its expression levels in B16/F10 cancer cells were investigated using immunohistochemical staining. The molecular mechanisms behind DMAKO20 activity against melanoma was investigated by using cytotoxicity, cell scratching, apoptotic, and immunoblotting assays. Results: CYP1B1, the P450 isoform was expressed at high levels in melanoma tissues and cultured B16/F10 cells, but was undetectable in normal tissues or fibroblasts. In cell proliferation assays, the shikonin oxime DMAKO-20 exhibited potent and selective antiproliferative effects against B16/F10 melanoma cells and inhibited migration. Several mechanisms for the anticancer effects of DMAKO-20 have been identified in B16/F10 melanoma cells, including apoptosis, upregulation of mitochondrial apoptotic Bax proteins and downregulation of anti-apoptotic Bcl-2. The results from these mechanistic investigations indicated that DMAKO-20 underwent CYP1B1-mediated metabolic activation to activate anticancer metabolites within melanoma cells. Conclusion: DMAKO-20 exhibited a selective cytotoxic effect on melanoma cells through CYP1B1-mediated activation. Using DMAKO-20 as a lead compound, further structural optimization may provide new drug entities for the treatments of malignant skin carcinomas.
Florid central nervous system vasculitis in a fatal case of systemic lupus erythematosus.

R. Bunning,R. Laureno,W. Barth

1982-09-01

Abstract:
An acetylated mannan isolated from Aloe vera induce colorectal cancer cells apoptosis via mitochondrial pathway

Xueli Tong,Chunqin Lao,Di Li,Junxi Du,Jingmian Chen,Weijie Xu,Lu Li,Huiling Ye,Xiaofeng Guo,Jiejing Li

DOI: https://doi.org/10.1016/j.carbpol.2022.119464

IF: 10.723

2022-04-01

Carbohydrate Polymers

Abstract:The anti-cancer effects of Aloe vera barbadensis extract C (AVBEC) have been demonstrated in a previous study. However, the specific functional ingredient and mechanism remain undefined. This study aimed to evaluate the function and associated mechanisms of purified polysaccharide (ABPA1) from AVBEC on colorectal cancer. Here, we identify that ABPA1 can induce colorectal cancer apoptosis. In vivo, ABPA1 significantly suppressed tumor growth in an orthotopic colon cancer model. Mechanistically, ABPA1 alters mitochondrial membrane permeability by promoting Bax translocation while causing cytochrome-c release, which initiates the caspase cascade reaction. Additionally, we found that ABPA1 exerted distinct impacts on the mitochondrial metabolism of colorectal cancer cells. Our study elucidated the mechanism by which the polysaccharide ABPA1 induces apoptosis in colorectal cancer cells through the regulation of Bax and cytochrome-c mediated mitochondrial pathway, indicating that ABPA1 may be developed as a mitochondrial-targeting anti-cancer drug.

polymer science,chemistry, organic, applied
Inhibitory Effects and Mechanisms of the Novel Shikonin Derivative DMAKO-20 on Melanoma Metastasis and Invasion

Xiaobo Zhou,Jia Huang,Shuoguo Liu,Jiahua Cui,Jun Chen

DOI: https://doi.org/10.24976/Discov.Med.202436185.113

Abstract:Background: Cutaneous melanoma is a malignant tumor with an increasing incidence, prone to recurrence and metastasis. This study aims to explore the effects and mechanisms of the novel shikonin derivative 5,8-dimethyl alkannin oxime derivative (DMAKO-20) on the metastasis and invasion of melanoma cells. Methods: The inhibitory effects of DMAKO-20 on the melanoma cell line A375 were investigated through Cell Counting Kit-8 (CCK-8), Transwell and angiogenesis experiments. Network pharmacology and Gene Ontology (GO)/Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were employed to explore potential sites and pathways involved in this process. Additionally, quantitative polymerase chain reaction (qPCR) and Western blot experiments were conducted before and after drug treatment to verify the expression trends of related pathways and proteins. Results: DMAKO-20 demonstrated selective inhibition of proliferation, invasion and migration of melanoma cells at low concentrations. The WNT pathway appears to be implicated in this process, as DMAKO-20 effectively attenuates its activation, consequently reducing matrix metalloproteinase 9 (MMP9) and Cellular Communication Network Factor 1 (CCN1)/cysteine-rich angiogenic inducer 61 (CYR61) levels. Such modulation inhibits melanoma dissemination and invasion into other tissues. Conclusion: DMAKO-20 exhibits the capability to suppress metastasis and invasion of melanoma cells, suggesting its potential for clinical application as an adjuvant therapy against melanoma.

[Trachomatous entropion trichiasis and its surgical treatment].

Β,β-Dimethylacrylshikonin Induces Mitochondria Dependent Apoptosis Through ERK Pathway in Human Gastric Cancer SGC-7901 Cells.

The In Vitro and In Vivo Anticancer Properties of Chalcone Flavokawain B through Induction of ROS-Mediated Apoptotic and Autophagic Cell Death in Human Melanoma Cells

Biochanin A induces anticancer effects in SK-Mel-28 human malignant melanoma cells via induction of apoptosis, inhibition of cell invasion and modulation of NF-κB and MAPK signaling pathways

Ailanthone Induces Cell Cycle Arrest and Apoptosis in Melanoma B16 and A375 Cells

Effects of Matrine on the Proliferation and Apoptosis Induction in Human Malignant Melanoma Cell Line A375

Experimental Dipetalonema reconditum infections in dogs.

Inhibitory effect of matrine on the in vitro invasiveness of human malignant melanoma cell line A375

The Inhibitory Effect of 3Β-Hydroxy-12-oleanen-27-oic Acid on Growth and Motility of Human Hepatoma HepG2 Cells Through JNK and Akt Signaling Pathway

Effect of resveratrol on the proliferation and apoptosis of melanoma cell line A375 cells

Axitinib, a selective inhibitor of vascular endothelial growth factor receptor, exerts an anticancer effect in melanoma through promoting antitumor immunity.

TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient

Shikonin Derivative Dmako-05 Inhibits Akt Signal Activation and Melanoma Proliferation

5-aminolevulinic-acid-mediated sonodynamic therapy improves the prognosis of melanoma by inhibiting survivin expression

Nitidine Chloride Inhibits Proliferation and Induces Mitochondrial-Mediated Apoptosis of Human Melanoma A375 and A2058 Cells In Vitro

A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products

Anti-cancer activity of Annexin V in murine melanoma model by suppressing tumor angiogenesis.

Selective Antitumor Effect of Shikonin Derived DMAKO-20 on Melanoma through CYP1B1

Florid central nervous system vasculitis in a fatal case of systemic lupus erythematosus.

An acetylated mannan isolated from Aloe vera induce colorectal cancer cells apoptosis via mitochondrial pathway

Inhibitory Effects and Mechanisms of the Novel Shikonin Derivative DMAKO-20 on Melanoma Metastasis and Invasion